ERβ, as opposed to ERα, is thought to have anti-proliferative, pro-apoptotic and anti-metastatic properties in cancer in general and PCa in particular, and could be an actionable therapeutic target in PCa (reviewed in [256, 257]). The gene discussed is ESR2; the disease is posterior cortical atrophy.